Friday, 25 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 27, 2025

XRP’s Historic December 2017 Surge Revisited—Could 2025 Set Up a Similar Move?

View original at finance.yahoo.com
XRP’s Historic December 2017 Surge Revisited—Could 2025 Set Up a Similar Move? Tsikhanovich Alena / Shutterstock.com Quick Read XRP rallied 1,200% in 6 weeks (December 2017): $0.25 to $3.30 driven by retail FOMO, exchange listings, Bitcoin hitting $20K…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Steady 50-100% gains could push XRP to $3-4 by mid-2026, or price could remain range-bound between $1.80-$2.50 as institutions accumulate slowly

    80% confidence
  • Over 1.35 billion XRP tokens have been removed from circulation into long-term custody, representing 45% less supply available for sale

    80% confidence
  • A repeat of the 1,200% rally is possible in December 2025 if catalysts, sentiment, adoption, and structure align

    80% confidence
  • 2025 replaces retail mania with institutional firepower: $1.1B ETF inflows in 4 weeks, SEC settlement August 2025, RLUSD at $1B market cap

    80% confidence
  • 2017 had zero institutional participation vs measured allocations in 2025; no regulatory clarity vs SEC settlement; pure speculation vs banks using ODL ($1.3B quarterly)

    80% confidence
  • Social media was flooded with 'XRP to $10' predictions during the 2017 rally

    80% confidence
  • XRP rallied 1,200% in 6 weeks from December 2017, driven by retail FOMO, exchange listings, and Bitcoin hitting $20K

    80% confidence

Data points we hold from this source

XRP · circulating supply reduction1.35 billion_tokens
XRP · stock price range1.80-2.20 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com